AbsTrACT background Polycystic ovarian syndrome (PCOS) is the most common cause of female infertility and is associated with higher levels of circulating androgens. Exposure to higher levels of androgens in utero may be a risk factor for obesity among children of women with PCOS. Methods We examined whether maternal PCOS was associated with differences in offspring growth and obesity in the Upstate KIDS study, a prospective cohort study of infants born in New York State (excluding New York City) oversampled for fertility treatments and multiple births. Measurements of offspring length/height and weight were recorded at doctor's visits through 3 years of age. PCOS diagnosis was self-reported by mothers at baseline. We used linear mixed models with robust SEs to estimate differences in growth by maternal PCOS exposure. We used logistic regression to examine whether infants experienced rapid weight gain at 4, 9 and 12 months. Growth measures were reported by 4098 mothers for 4949 children (1745 twins). Of these, 435 mothers (10.6%) had a diagnosis of PCOS. results Compared with children born to mothers without PCOS, children of mothers with PCOS did not have significant differences in weight (4.81 g, 95% CI −95.1 to 104.7), length/height (0.18 cm, 95% CI −0.16 to 0.52) and body mass index (−0.14 kg/m 2 , 95% CI −0.30 to 0.01) through 3 years of age. We also observed no association between maternal PCOS and offspring rapid weight gain. Conclusions Overall, we found little evidence to suggest that maternal PCOS influences early childhood growth in this large, prospective cohort study.
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bACkground
Polycystic ovarian syndrome (PCOS) is the most common cause of female infertility.
1 Approximately 6%-15% of women in the USA have PCOS.
2 PCOS is a complex syndrome with several characteristic features, including obesity, insulin resistance, hyperandrogenaemia and ovarian cysts. Mothers with PCOS are at increased risk of gestational diabetes, hypertension, endothelial dysfunction and pre-eclampsia, which can alter the fetal endocrine environment, leading to adverse outcomes in offspring, 2 such as low birth weight, metabolic derangements, congenital abnormalities and perinatal mortality. 3 While relationships between maternal PCOS and birth outcomes have been well studied, few studies have examined whether maternal PCOS has effects on early childhood growth, and results of these studies are mixed. [2] [3] [4] One small study of boys born to mothers with PCOS reported higher body weight in infancy and childhood compared with boys born to mothers without PCOS. 5 A study of girls born to mothers with PCOS that paid particular attention to PCOS phenotyping using National Institutes of Health criteria in cases and controls found no difference in body size in adolescence compared with offspring born to mothers without PCOS. 6 Most studies relied on only one measurement of growth and were smaller in size (n<300). 7 8 Other studies have found that offspring were more likely to be born small for gestational age (SGA), and children born SGA are often at higher risk of smaller stature in childhood and adolescence. 7 9 10 Animal studies have suggested PCOS exposure is associated with heavier offspring potentially due to insulin resistance and related in utero hyperglycaemia exposure. 2 11 No large cohort studies have examined whether young children born to mothers with PCOS show differences in growth compared with young children born to mothers without PCOS.
MeThods
We used data from the Upstate KIDS study, a population-based, prospective cohort study of children born 2008-2010 in New York State (excluding New York City). 12 Briefly, the study aimed to examine the effects of infertility treatment on child health outcomes. 12 Eligible children were identified using the New York State live birth registry. All singletons whose birth certificates indicated they were conceived using fertility treatments and all multiple births, regardless of conception method, were recruited. Singleton children not conceived using infertility treatments were frequency matched to singletons who were conceived using treatments by region of residence using a 3:1 ratio. Data from mothers and their children were included if the mothers reported PCOS status and the children had at least one growth measurement. In total, 5034 mothers enrolled with their 6171 children. Children with at least one growth measurement were included for analysis.
exposure measurement
Mothers completed a baseline questionnaire at 4 months post-pregnancy, which included questions about demographic, gynaecological and reproductive health, diet and lifestyle factors regarding the pregnancy, and child(ren) enrolled in the study. Mothers were classified as exposed if they reported that a doctor or healthcare provider had diagnosed them with PCOS.
short report outcome measurement
Mothers were given child health journals in their study invitation packets and were encouraged to use them to record weight and length/height as measured at visits with healthcare providers through 3 years of age. Questionnaires were sent to mothers every 4-6 months that included questionnaires to capture growth data recorded in the journals. Questionnaires featured a grid that allowed mothers to record multiple growth entries at different points in time as the child aged. Entries in which a child's length decreased by more than 1 cm from the previous measurement were excluded. Height and weight were standardised using z-scores based on WHO Child Growth Standards. We also examined whether infants had rapid weight gain at the 4-month, 9-month and 12-month time periods. Rapid weight gain was assessed by examining the observed differences in weight between the 4-month, 9-month and 12-month periods and comparing them with predicted differences at those periods. Briefly, predicted SD scores (SDS) were generated using an individual child's change in weight over time, and those scores were compared with children in the rest of the sample. If a child's SDS was above 0.5 in the 4-month or 9-month period, or above 0.67 for the 12-month period, they were classified as having rapid weight gain.
statistical analyses
We generated descriptive statistics of demographic and biological characteristics for participants with and without PCOS. We used generalised linear mixed models to explore the differences between self-report of maternal PCOS and growth parameters in offspring up to 36 months of age. All models used an infant-level random intercept to account for repeated measures of growth over time and a maternal-level intercept to account for multiple births. We also examined whether offspring experienced rapid weight gain or growth in the 4-month, 9-month or 12-month periods using logistic regression. Sampling weights were applied to all models to account for oversampling of twins and infants conceived by fertility treatment.
The following covariates from birth certificates and maternal self-report were used: maternal age at delivery, race/ethnicity, highest achieved educational level, marital status, health insurance status, plurality, maternal smoking during pregnancy (yes/ no), alcohol consumption during pregnancy (yes/no), history of infertility treatment, pre-pregnancy diabetes and pre-pregnancy body mass index (BMI). Missing covariate data (but not growth data) were imputed using Markov chain Monte Carlo multiple imputation. Analyses were performed using SAS V.9.4 (SAS Institute, Cary, North Carolina, USA). 
short report resulTs
Of 5034 mothers enrolled in the study, 4438 reported at least one measurement of growth for the enrolled child, and of those, 4098 also reported PCOS status. Mothers with PCOS were more likely to be better educated, overweight or obese, used infertility treatment, have pre-pregnancy diabetes and have private insurance compared with mothers without PCOS (table 1) . Mothers with PCOS were also less likely to smoke or drink alcohol while pregnant compared with mothers without PCOS. Offspring of mothers with PCOS were not significantly different in size compared with offspring of mothers without PCOS. In fully adjusted analyses (table 2), these children had non-significant differences in weight (4.81 g, 95% CI −95.09 to 104.71), length (0.18 cm, 95% CI −0.16 to 0.52) and BMI (−0.14 kg/m 2 , 95% CI −0.30 to 0.01). Use of weight, length and BMI measures standardised using z-scores also showed no difference. When examining singletons and twins separately or by infant gender, we also observed no differences in weight, length or BMI. We also observed no difference by gender (not shown). In our analysis of rapid weight gain, we found no evidence of differences by maternal PCOS status after adjustment for confounders (online supplemental material) among all children or when examining singletons and twins separately. In an analysis stratified by fertility treatment, we observed only slight differences that did not change our results (online supplemental material). In all, we found no significant evidence that children born to mothers with PCOS had higher odds of rapid weight gain compared with children born to mothers without PCOS in this time window.
disCussion
We found little evidence that being born to mothers with PCOS was associated with differences in weight, length/height or BMI in the first 36 months of life. We also did not observe an association when examining associations within singletons and twins separately. We found little evidence of an association between maternal PCOS and rapid weight gain. This is the first report examining maternal PCOS and early childhood growth from a large, prospective cohort study. Our study confirms results of studies reporting no associations between maternal PCOS and offspring growth in adolescents and those whose mothers were prescribed medication for PCOS. 6 7 14 Treatment with medication may have reduced the PCOS-related hyperandrogenic and insulin resistance-associated exposures in utero. Information on specific medications mothers with PCOS may have used before or during pregnancy was unavailable in our study, but use of treatment for PCOS may contribute to our finding of no association. A study of dizygotic twins found no differences in growth between opposite-sex and same-sex twins in utero, suggesting that exposure to androgens in utero had little impact on height and BMI in adulthood. 15 Exposure to higher levels of circulating androgens in utero have been associated with greater body weight gain in infantile development in some animal studies, however.
2 A study reporting differences in BMI among boys by PCOS exposure was small in size (n=136) and did not adjust for confounding, which may have biased the results. 5 Methodological strengths and limitations of this study should be considered. This was a large, population-based prospective cohort study with repeated measurements of child growth and detailed measurement of confounders. PCOS status was measured by self-report prior to measurement of growth outcomes, so growth measures could not have influenced PCOS reporting. Questionnaires were not able to distinguish between different PCOS phenotypes however, which may be relevant to child growth impact. As there can be a long delay between symptom presentation and diagnosis in PCOS, women who did not undergo fertility treatment may have undiagnosed PCOS, which may bias estimates towards the null. It is possible that mothers with lower socioeconomic status (SES) may be underdiagnosed for PCOS. If misclassification occurred by SES, this may falsely increase estimates of growth among children of mothers without PCOS. Hence, we cannot rule out missing potentially small effects. Weight and length/height may be measured inaccurately; however, we are unaware of data suggesting reporting of size would systematically vary by PCOS status in such a way that would bias our findings.
In conclusion, we found that children born to mothers with PCOS grew similarly compared with children born to mothers without PCOS. PCOS can be heritable and affect adult weight and metabolic function; however, we did not find evidence that growth was programmed in utero and measurable in children born to mothers with PCOS.
2
What is already known on this subject ► Polycystic ovarian syndrome (PCOS) is the most common cause of infertility and is associated with higher levels of androgens in women. Studies of hyperandrogenic mothers have shown increased risk of adverse birth outcomes in offspring; however, few studies have examined whether exposure to maternal PCOS in utero is associated with differences in early childhood growth.
What does this study add
► In this population-based, longitudinal birth cohort study of mothers and their offspring in New York State, we saw little evidence of differences early childhood growth by maternal PCOS status. Further study is needed to confirm this result.
Contributors GAB conceptualised and designed the study, carried out the initial analyses, drafted the initial manuscript, and reviewed and revised the manuscript. SLM, MB, HP and JM conceptualised and designed the study, made substantial contributions to analysis and interpretation of data, and critically revised the manuscript. EMB, EHY and RS collected data, designed the data collection instruments, coordinated and supervised data collection, and critically reviewed the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Funding Supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; contract nos. HHSN275201200005C, HHSN267200700019C).
disclaimer The funders played no role in the study design, data collection, data analysis or interpretation, writing of the manuscript or the decision to submit the article for publication. All individuals listed as authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
